280 related articles for article (PubMed ID: 25257577)
21. Atypical leiomyomas of the uterus: a clinicopathologic study of 51 cases.
Ly A; Mills AM; McKenney JK; Balzer BL; Kempson RL; Hendrickson MR; Longacre TA
Am J Surg Pathol; 2013 May; 37(5):643-9. PubMed ID: 23552381
[TBL] [Abstract][Full Text] [Related]
22. Uterine Morcellation: Fact and Fiction Surrounding the Recent Controversy.
Winner B; Biest S
Mo Med; 2017; 114(3):176-180. PubMed ID: 30228576
[TBL] [Abstract][Full Text] [Related]
23. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
[TBL] [Abstract][Full Text] [Related]
24. Leiomyoadenomatoid tumor of the uterus: report of a rare entity and review of the literature.
Sarma NH; Srinivasulu M; Suchitra MJ
Indian J Pathol Microbiol; 2014; 57(3):450-2. PubMed ID: 25118743
[TBL] [Abstract][Full Text] [Related]
25. Transvaginal morcellation.
Clark Donat L; Clark M; Tower AM; Menderes G; Parkash V; Silasi DA; Azodi M
JSLS; 2015; 19(2):. PubMed ID: 26005318
[TBL] [Abstract][Full Text] [Related]
26. To Assess the Safety of Morcellation for Removing Uterine Specimen During Laparoscopic and Vaginal Hysterectomies for Leiomyomas.
Agrawal P; Agrawal R; Chandrakar J
J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):567-72. PubMed ID: 27651662
[TBL] [Abstract][Full Text] [Related]
27. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
Cui RR; Wright JD
Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
[TBL] [Abstract][Full Text] [Related]
28. Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH).
Bojahr B; De Wilde RL; Tchartchian G
Arch Gynecol Obstet; 2015 Sep; 292(3):665-72. PubMed ID: 25820974
[TBL] [Abstract][Full Text] [Related]
29. Medical Device Safety and Surgical Dissemination of Unrecognized Uterine Malignancy: Morcellation in Minimally Invasive Gynecologic Surgery.
Hall T; Lee SI; Boruta DM; Goodman A
Oncologist; 2015 Nov; 20(11):1274-82. PubMed ID: 26382742
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic power morcellation of presumed fibroids.
Brolmann HA; Sizzi O; Hehenkamp WJ; Rossetti A
Minerva Ginecol; 2016 Jun; 68(3):352-63. PubMed ID: 26799759
[TBL] [Abstract][Full Text] [Related]
31. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
Wasson M; Magtibay P; Magtibay P; Magrina J
J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.
Lee JY; Kim HS; Nam EJ; Kim SW; Kim S; Kim YT
BMC Cancer; 2016 Aug; 16(1):675. PubMed ID: 27553655
[TBL] [Abstract][Full Text] [Related]
33. [Adenomatoid tumor of the uterus--2 case reports].
Dietterle S; Hantschick M; Stosiek P
Zentralbl Gynakol; 1997; 119(2):82-5. PubMed ID: 9139502
[TBL] [Abstract][Full Text] [Related]
34. [LAPAROSCOPIC TREATMENT OF INTRALIGAMENTAL LEIOMYOMA PER MAGNA].
Bechev B; Magunska N; Kovachev E; Ivanov S
Akush Ginekol (Sofiia); 2016; 55(1):66-8. PubMed ID: 27514135
[TBL] [Abstract][Full Text] [Related]
35. [An adenomatoid tumor of the uterus].
Buzzi A; Pezzica E; Crescini C
Minerva Ginecol; 1994 Jun; 46(6):359-64. PubMed ID: 7936389
[TBL] [Abstract][Full Text] [Related]
36. Unanticipated uterine pathologic finding after morcellation during robotic-assisted supracervical hysterectomy and cervicosacropexy for uterine prolapse.
Hill AJ; Carroll AW; Matthews CA
Female Pelvic Med Reconstr Surg; 2014; 20(2):113-5. PubMed ID: 24566217
[TBL] [Abstract][Full Text] [Related]
37. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease.
Von Bargen EC; Grimes CL; Mishra K; Wang R; Haviland MJ; Hacker MR; Carnevale JA; Estes AJ; Elkadry EA
Int J Gynaecol Obstet; 2017 May; 137(2):123-128. PubMed ID: 28170091
[TBL] [Abstract][Full Text] [Related]
39. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome.
Pedra Nobre S; Hensley ML; So M; Zhou QC; Iasonos A; Leitao MM; Ducie J; Chiang S; Mueller JJ; Abu-Rustum NR; Zivanovic O
Gynecol Oncol; 2021 Jan; 160(1):99-105. PubMed ID: 33158511
[TBL] [Abstract][Full Text] [Related]
40. Incidence of Tissue Morcellation During Surgery for Uterine Sarcoma at a Canadian Academic Centre.
Chen I; Hopkins L; Firth B; Boucher J; Singh SS
J Obstet Gynaecol Can; 2015 May; 37(5):421-425. PubMed ID: 26168102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
